Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
142.00Prev. Close
135.50Volume
0Total traded value
NAUpper Circuit
142.27Lower Circuit
128.72Fundamentals
| Market Cap | ₹403Cr |
| ROE | -10.16% |
| P/E Ratio(TTM) | 198.26 |
| EPS(TTM) | 0.69 |
| P/B Ratio | 4.11 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.86 |
| Book Value | 33.30 |
| Debt to Equity | 0.08 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Brooks Laboratories
Brooks Laboratories is a pharmaceutical manufacturing company that works on a contract basis and also has its own marketing team for the critical care segment. The company's core value is to advance its mission by acting in the best interests of the organization and its workforce when developing services. Demonstrating strong performance, the company's standalone turnover experienced a significant 43.12% surge in the 2023-24 financial year.;
| Parent Organisation | Brooks Laboratories |
| Managing Director | Mr. Rajesh Mahajan |
| NSE Symbol | BROOKS |
Shareholding Pattern
Sep '24
Dec '24
Jan '25
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 100.21 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.19 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.70 | ||
| Wockhardt | NA (0.00%) | -176.41 |